Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Convergent Ventures is a venture capital firm founded by a diverse team of founders, scientists, and physicians with extensive experience in early-stage investments. Established in San Francisco and New York City, the firm is dedicated to supporting early-stage teams that leverage science-driven technologies to advance health and sustainability. The organization operates primarily in North America and focuses on pre-seed, seed, seed-plus, and Series A funding stages. While specific fund sizes and assets under management are not publicly disclosed, Convergent Ventures emphasizes collaboration with multiple investors to enhance their market and technical expertise. This collaborative approach not only strengthens their investment strategy but also positions them as a key player in the startup ecosystem, particularly in sectors that require innovative solutions to pressing societal challenges.
Convergent Ventures invests in differentiated technologies that lie at the intersection of data and the natural, physical, and human sciences. Their investment focus spans several critical sectors, including healthcare, biotech, and climate. The firm seeks scalable business models that promise significant societal impacts alongside financial returns. By prioritizing science-driven technologies, Convergent Ventures aims to back companies that are not only innovative but also capable of addressing urgent global issues. They actively seek partnerships with other investors to bolster their market presence and technical capabilities, ensuring that their portfolio companies receive the support they need to thrive. This strategic focus on collaboration and innovation makes Convergent Ventures a unique player in the venture capital landscape, particularly for startups aiming to make a meaningful difference in health and sustainability.
Convergent Ventures boasts a notable portfolio of companies that exemplify their commitment to investing in innovative technologies. Among their key investments is **Ubicept**, which develops photon fusion technology aimed at enhancing vehicle safety systems. Another significant portfolio company is **Novamera**, which focuses on breakthrough surgical mining technology for the production of critical minerals and metals. Additionally, **Biotia** partners with healthcare institutions to provide AI-driven orthopedic diagnostics, while **FIGUR8** engages in health monitoring and diagnostics. Other noteworthy investments include **Dandelion Health**, which works on innovative health solutions, and **Contraline**, known for its novel hydrogel platform for long-lasting, reversible contraception. This diverse portfolio reflects Convergent Ventures' strategic focus on sectors that intersect health and sustainability, showcasing their commitment to supporting transformative technologies.
Convergent Ventures focuses on early-stage investments, specifically targeting pre-seed, seed, seed-plus, and Series A funding rounds. This approach allows them to support startups at critical points in their development.
The firm primarily invests in sectors related to healthcare, biotech, and climate. They seek companies that leverage science-driven technologies to create scalable business models with significant societal impacts.
While specific pitch preferences are not detailed, it is advisable to highlight the scientific and technological aspects of your startup, particularly how it addresses health and sustainability challenges. Collaboration with other investors may also be beneficial.
Convergent Ventures primarily focuses on the North American market, with operations based in San Francisco and New York City. This geographic focus allows them to engage closely with the local startup ecosystem.
Specific check sizes are not disclosed, but the firm invests in early-stage rounds, which typically range from pre-seed to Series A funding. Founders should prepare for varying investment amounts based on their stage and needs.
Convergent Ventures emphasizes collaboration with multiple investors, which suggests they may provide access to a broader network of resources and expertise. However, specific support mechanisms are not detailed in the available information.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.